Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) EVP Joseph Konowiecki sold 4,930 shares of the company’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $7.20, for a total transaction of $35,496.00. Following the transaction, the executive vice president owned 1,075,375 shares in the company, valued at approximately $7,742,700. The trade was a 0.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Alignment Healthcare Trading Down 1.9%
Shares of NASDAQ ALHC traded down $0.14 during mid-day trading on Friday, hitting $7.36. The company’s stock had a trading volume of 2,723,989 shares, compared to its average volume of 5,384,573. Alignment Healthcare, Inc. has a one year low of $6.01 and a one year high of $25.12. The company’s fifty day simple moving average is $8.66 and its 200-day simple moving average is $16.07. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.71 and a quick ratio of 1.71. The stock has a market cap of $1.54 billion, a price-to-earnings ratio of 56.62 and a beta of 1.07.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The company reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04). Alignment Healthcare had a net margin of 0.59% and a return on equity of 12.46%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the previous year, the firm posted $0.02 earnings per share. Alignment Healthcare’s revenue for the quarter was up 36.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.03 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Alignment Healthcare
Hedge funds and other institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. grew its stake in shares of Alignment Healthcare by 9.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company’s stock worth $202,000 after acquiring an additional 962 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Alignment Healthcare by 46.6% in the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock worth $80,000 after purchasing an additional 1,070 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Alignment Healthcare by 463.3% in the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after purchasing an additional 1,135 shares in the last quarter. Benjamin Edwards Inc. lifted its position in shares of Alignment Healthcare by 2.7% in the third quarter. Benjamin Edwards Inc. now owns 51,551 shares of the company’s stock worth $421,000 after purchasing an additional 1,351 shares in the last quarter. Finally, Nykredit A S acquired a new position in Alignment Healthcare during the second quarter worth $36,000. 86.19% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research firms have recently issued reports on ALHC. William Blair lowered Alignment Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, October 9th. Barclays dropped their price objective on Alignment Healthcare from $10.00 to $9.00 and set an “equal weight” rating for the company in a report on Friday, October 30th. Needham & Company LLC started coverage on Alignment Healthcare in a report on Wednesday, October 28th. They set a “hold” rating on the stock. Raymond James Financial restated an “outperform” rating on shares of Alignment Healthcare in a report on Monday, October 12th. Finally, Piper Sandler restated an “overweight” rating and set a $15.00 target price on shares of Alignment Healthcare in a research report on Friday, October 30th. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $14.00.
View Our Latest Stock Analysis on Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc. is a technology-enabled healthcare company focused primarily on serving older adults through Medicare Advantage plans. Its health plans, offered under the Alignment Health Plan name, combine insurance coverage with care coordination and support intended to address members’ medical and everyday health needs. The company uses a care model that includes personalized care teams, member support and technology to help coordinate services across providers. Its Medicare Advantage offerings include plan options such as HMO and PPO products, with availability and benefits varying by location.
Recommended Stories
- Five stocks we like better than Alignment Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
